| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vestibular Diseases | 10 | 2023 | 217 | 3.970 |
Why?
|
| Abnormalities, Multiple | 16 | 2023 | 1416 | 3.910 |
Why?
|
| Hematologic Diseases | 9 | 2023 | 498 | 2.960 |
Why?
|
| Neonatal Screening | 19 | 2017 | 591 | 2.620 |
Why?
|
| Histone Demethylases | 7 | 2023 | 321 | 2.260 |
Why?
|
| Fabry Disease | 10 | 2014 | 90 | 2.210 |
Why?
|
| Guanidinoacetate N-Methyltransferase | 10 | 2017 | 11 | 2.180 |
Why?
|
| Gaucher Disease | 11 | 2022 | 112 | 2.130 |
Why?
|
| Glycogen Storage Disease Type II | 9 | 2017 | 41 | 2.120 |
Why?
|
| Face | 9 | 2021 | 994 | 1.970 |
Why?
|
| Creatine | 11 | 2017 | 421 | 1.920 |
Why?
|
| Tandem Mass Spectrometry | 17 | 2020 | 1157 | 1.850 |
Why?
|
| Metabolism, Inborn Errors | 11 | 2020 | 288 | 1.260 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 9 | 2017 | 255 | 1.240 |
Why?
|
| Congenital Disorders of Glycosylation | 4 | 2020 | 45 | 1.240 |
Why?
|
| Neoplasm Proteins | 8 | 2021 | 3703 | 1.200 |
Why?
|
| Mucopolysaccharidosis II | 6 | 2013 | 27 | 1.100 |
Why?
|
| Acidosis, Lactic | 2 | 2023 | 142 | 1.010 |
Why?
|
| Niemann-Pick Disease, Type C | 3 | 2023 | 51 | 1.010 |
Why?
|
| Carnitine | 9 | 2007 | 246 | 0.980 |
Why?
|
| Phenotype | 27 | 2023 | 16365 | 0.930 |
Why?
|
| Methylmalonic Acid | 6 | 2009 | 49 | 0.880 |
Why?
|
| DNA-Binding Proteins | 10 | 2021 | 9648 | 0.870 |
Why?
|
| Limb Deformities, Congenital | 2 | 2020 | 136 | 0.850 |
Why?
|
| Tay-Sachs Disease | 1 | 2022 | 17 | 0.840 |
Why?
|
| Glucosylceramidase | 7 | 2022 | 124 | 0.830 |
Why?
|
| alpha-Glucosidases | 4 | 2014 | 44 | 0.820 |
Why?
|
| Lysosomal Storage Diseases | 7 | 2021 | 79 | 0.790 |
Why?
|
| Infant, Newborn | 55 | 2023 | 25625 | 0.790 |
Why?
|
| Wolfram Syndrome | 1 | 2020 | 13 | 0.770 |
Why?
|
| Amidinotransferases | 2 | 2017 | 11 | 0.770 |
Why?
|
| Blood Specimen Collection | 5 | 2010 | 246 | 0.760 |
Why?
|
| Chromatography, High Pressure Liquid | 9 | 2014 | 1572 | 0.740 |
Why?
|
| Mutation | 33 | 2023 | 29786 | 0.740 |
Why?
|
| Glycolipids | 4 | 2014 | 204 | 0.730 |
Why?
|
| Phenylketonurias | 4 | 2014 | 122 | 0.730 |
Why?
|
| Holoprosencephaly | 1 | 2019 | 22 | 0.730 |
Why?
|
| Craniofacial Abnormalities | 2 | 2020 | 315 | 0.710 |
Why?
|
| Polyhydramnios | 1 | 2019 | 41 | 0.710 |
Why?
|
| Cataract | 2 | 2023 | 834 | 0.710 |
Why?
|
| Homocystinuria | 4 | 2005 | 67 | 0.700 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2020 | 129 | 0.690 |
Why?
|
| Osteosclerosis | 1 | 2019 | 39 | 0.690 |
Why?
|
| Mucopolysaccharidosis I | 3 | 2015 | 50 | 0.690 |
Why?
|
| Casein Kinase I | 1 | 2019 | 47 | 0.680 |
Why?
|
| Glycocalyx | 1 | 2020 | 88 | 0.680 |
Why?
|
| Microcephaly | 3 | 2019 | 432 | 0.660 |
Why?
|
| Muscular Diseases | 1 | 2023 | 556 | 0.660 |
Why?
|
| Exophthalmos | 1 | 2019 | 97 | 0.650 |
Why?
|
| Infant | 51 | 2023 | 35136 | 0.640 |
Why?
|
| Rare Diseases | 5 | 2023 | 553 | 0.630 |
Why?
|
| Iduronidase | 3 | 2015 | 31 | 0.630 |
Why?
|
| Sphingolipids | 3 | 2014 | 159 | 0.630 |
Why?
|
| Noonan Syndrome | 2 | 2015 | 122 | 0.610 |
Why?
|
| Rett Syndrome | 2 | 2011 | 165 | 0.610 |
Why?
|
| Child, Preschool | 49 | 2023 | 41006 | 0.600 |
Why?
|
| Arginine | 2 | 2012 | 944 | 0.600 |
Why?
|
| Alkaptonuria | 1 | 2017 | 13 | 0.590 |
Why?
|
| Cleft Palate | 2 | 2021 | 560 | 0.590 |
Why?
|
| alpha-Galactosidase | 4 | 2014 | 57 | 0.590 |
Why?
|
| Fluorometry | 2 | 2013 | 106 | 0.570 |
Why?
|
| Leucine | 7 | 2006 | 561 | 0.550 |
Why?
|
| Glycine | 6 | 2009 | 671 | 0.550 |
Why?
|
| Vitamin B 12 Deficiency | 3 | 2009 | 116 | 0.540 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 2 | 2017 | 19 | 0.540 |
Why?
|
| Stomach | 1 | 2020 | 697 | 0.540 |
Why?
|
| Color | 1 | 2017 | 307 | 0.530 |
Why?
|
| Fetal Growth Retardation | 1 | 2019 | 570 | 0.530 |
Why?
|
| Maze Learning | 1 | 2017 | 478 | 0.530 |
Why?
|
| Sphingomyelin Phosphodiesterase | 3 | 2012 | 91 | 0.520 |
Why?
|
| Vitamin B 12 | 7 | 2013 | 527 | 0.520 |
Why?
|
| Urine | 1 | 2017 | 370 | 0.520 |
Why?
|
| Genetic Association Studies | 6 | 2020 | 2703 | 0.510 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 849 | 0.500 |
Why?
|
| Mucopolysaccharidosis III | 1 | 2014 | 11 | 0.500 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2020 | 770 | 0.500 |
Why?
|
| Motor Skills | 1 | 2017 | 522 | 0.480 |
Why?
|
| Transcobalamins | 2 | 2013 | 18 | 0.480 |
Why?
|
| Humans | 175 | 2023 | 744343 | 0.470 |
Why?
|
| Pancreas Transplantation | 1 | 2014 | 187 | 0.470 |
Why?
|
| Epiphyses | 1 | 2014 | 189 | 0.470 |
Why?
|
| Osteochondrodysplasias | 1 | 2014 | 183 | 0.450 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2023 | 1836 | 0.450 |
Why?
|
| Mutation, Missense | 5 | 2019 | 2564 | 0.440 |
Why?
|
| Genotype | 9 | 2023 | 12951 | 0.430 |
Why?
|
| Growth Disorders | 1 | 2017 | 645 | 0.430 |
Why?
|
| Alanine | 4 | 2006 | 572 | 0.430 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2017 | 736 | 0.420 |
Why?
|
| Amino Acids | 3 | 2007 | 1736 | 0.420 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 1912 | 0.410 |
Why?
|
| Blood Chemical Analysis | 2 | 2013 | 440 | 0.410 |
Why?
|
| Glycoproteins | 2 | 2013 | 2263 | 0.410 |
Why?
|
| Repressor Proteins | 2 | 2020 | 3023 | 0.390 |
Why?
|
| Language Development Disorders | 2 | 2017 | 196 | 0.390 |
Why?
|
| Glucose | 9 | 2009 | 4397 | 0.390 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 2 | 2004 | 167 | 0.390 |
Why?
|
| Nitric Oxide Synthase | 2 | 2012 | 916 | 0.390 |
Why?
|
| Hydroxocobalamin | 5 | 2013 | 31 | 0.380 |
Why?
|
| ras Proteins | 2 | 2015 | 1060 | 0.380 |
Why?
|
| Ear, External | 2 | 2010 | 161 | 0.370 |
Why?
|
| Child | 48 | 2023 | 77709 | 0.370 |
Why?
|
| Enzyme Replacement Therapy | 5 | 2015 | 78 | 0.370 |
Why?
|
| Biotinidase | 1 | 2010 | 19 | 0.370 |
Why?
|
| Tyrosinemias | 2 | 2007 | 10 | 0.360 |
Why?
|
| Family | 1 | 2021 | 3147 | 0.360 |
Why?
|
| Enzyme Assays | 1 | 2010 | 111 | 0.350 |
Why?
|
| Male | 87 | 2021 | 350118 | 0.340 |
Why?
|
| Caregivers | 1 | 2021 | 2094 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2010 | 658 | 0.330 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 4 | 2017 | 19 | 0.330 |
Why?
|
| Developmental Disabilities | 5 | 2020 | 1456 | 0.330 |
Why?
|
| Glutarates | 3 | 2015 | 236 | 0.330 |
Why?
|
| Propionic Acidemia | 3 | 2013 | 9 | 0.320 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2014 | 783 | 0.320 |
Why?
|
| Female | 85 | 2023 | 380194 | 0.320 |
Why?
|
| Mannose-Binding Lectin | 2 | 2006 | 150 | 0.320 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2014 | 3336 | 0.310 |
Why?
|
| 4-Hydroxyphenylpyruvate Dioxygenase | 1 | 2007 | 2 | 0.310 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1526 | 0.310 |
Why?
|
| Cyclohexenes | 1 | 2007 | 15 | 0.310 |
Why?
|
| Amino Acids, Sulfur | 1 | 2007 | 16 | 0.310 |
Why?
|
| Methionine | 2 | 2007 | 590 | 0.300 |
Why?
|
| Infertility, Male | 1 | 2011 | 409 | 0.300 |
Why?
|
| Isotope Labeling | 3 | 1997 | 406 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2007 | 230 | 0.290 |
Why?
|
| Motor Activity | 1 | 2017 | 2714 | 0.290 |
Why?
|
| DNA Mutational Analysis | 11 | 2011 | 4186 | 0.290 |
Why?
|
| Endothelial Cells | 1 | 2020 | 3479 | 0.290 |
Why?
|
| Blood Stains | 1 | 2006 | 8 | 0.290 |
Why?
|
| Aspartic Acid | 3 | 2010 | 576 | 0.290 |
Why?
|
| Psychomotor Disorders | 1 | 2007 | 152 | 0.290 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 3768 | 0.280 |
Why?
|
| Creatinine | 2 | 2009 | 1919 | 0.280 |
Why?
|
| Facial Bones | 1 | 2007 | 201 | 0.280 |
Why?
|
| Trisomy | 1 | 2007 | 266 | 0.270 |
Why?
|
| Adolescent | 38 | 2021 | 85781 | 0.270 |
Why?
|
| Ketosis | 1 | 2006 | 49 | 0.270 |
Why?
|
| Thrombosis | 1 | 2020 | 2968 | 0.270 |
Why?
|
| Orofaciodigital Syndromes | 1 | 2005 | 23 | 0.270 |
Why?
|
| Hematinics | 3 | 2005 | 281 | 0.260 |
Why?
|
| Methyltransferases | 4 | 2004 | 367 | 0.260 |
Why?
|
| Eye Abnormalities | 2 | 2020 | 246 | 0.260 |
Why?
|
| Membrane Proteins | 2 | 2020 | 7880 | 0.260 |
Why?
|
| Glycogen Storage Disease Type I | 2 | 2002 | 53 | 0.250 |
Why?
|
| Pedigree | 8 | 2020 | 4644 | 0.250 |
Why?
|
| Dermatan Sulfate | 2 | 2015 | 35 | 0.250 |
Why?
|
| Dietary Supplements | 2 | 2011 | 3297 | 0.250 |
Why?
|
| Chromosome Deletion | 2 | 2007 | 1401 | 0.250 |
Why?
|
| Liver Failure, Acute | 2 | 2017 | 165 | 0.250 |
Why?
|
| Energy Metabolism | 7 | 2001 | 2899 | 0.250 |
Why?
|
| Isotopes | 2 | 2001 | 124 | 0.250 |
Why?
|
| Homocysteine | 4 | 2012 | 647 | 0.240 |
Why?
|
| Breath Tests | 4 | 2002 | 280 | 0.240 |
Why?
|
| Hematocrit | 3 | 2012 | 636 | 0.240 |
Why?
|
| Carrier Proteins | 1 | 2017 | 5021 | 0.240 |
Why?
|
| Polymorphism, Genetic | 5 | 2011 | 4328 | 0.240 |
Why?
|
| Myosin Type I | 1 | 2023 | 19 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 4462 | 0.230 |
Why?
|
| Liver Transplantation | 1 | 2014 | 2119 | 0.230 |
Why?
|
| Chromosomes, Human, X | 1 | 2005 | 296 | 0.230 |
Why?
|
| Alleles | 8 | 2020 | 6933 | 0.230 |
Why?
|
| Betaine | 2 | 2005 | 87 | 0.220 |
Why?
|
| Heparitin Sulfate | 2 | 2015 | 225 | 0.220 |
Why?
|
| Aicardi Syndrome | 1 | 2023 | 17 | 0.220 |
Why?
|
| Starch | 1 | 2002 | 81 | 0.220 |
Why?
|
| Neural Stem Cells | 2 | 2021 | 851 | 0.210 |
Why?
|
| Facies | 3 | 2020 | 197 | 0.210 |
Why?
|
| Laryngismus | 1 | 2002 | 29 | 0.210 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2010 | 3760 | 0.210 |
Why?
|
| Iduronate Sulfatase | 3 | 2011 | 11 | 0.210 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 2 | 2017 | 44 | 0.210 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 5751 | 0.210 |
Why?
|
| Osteopetrosis | 1 | 2001 | 43 | 0.200 |
Why?
|
| Milk Hypersensitivity | 1 | 2022 | 76 | 0.200 |
Why?
|
| Genetic Testing | 6 | 2020 | 3444 | 0.200 |
Why?
|
| CHARGE Syndrome | 1 | 2021 | 31 | 0.200 |
Why?
|
| Quality of Life | 2 | 2022 | 12804 | 0.200 |
Why?
|
| Glycosylation | 2 | 2019 | 1126 | 0.200 |
Why?
|
| Sotos Syndrome | 1 | 2021 | 10 | 0.200 |
Why?
|
| Amniotic Band Syndrome | 1 | 2001 | 22 | 0.200 |
Why?
|
| Hypoglycemia | 2 | 2006 | 861 | 0.200 |
Why?
|
| Adult | 40 | 2023 | 214055 | 0.200 |
Why?
|
| Hydrogen | 2 | 2002 | 164 | 0.190 |
Why?
|
| Heterozygote | 6 | 2020 | 2804 | 0.190 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2023 | 437 | 0.190 |
Why?
|
| Muscle Cells | 1 | 2021 | 197 | 0.190 |
Why?
|
| Folic Acid | 3 | 2007 | 1300 | 0.190 |
Why?
|
| Porphyria, Acute Intermittent | 1 | 2000 | 15 | 0.180 |
Why?
|
| Protein Denaturation | 2 | 2011 | 237 | 0.180 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2021 | 670 | 0.180 |
Why?
|
| Hematoma, Subdural | 1 | 2001 | 126 | 0.180 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 1990 | 0.180 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2000 | 69 | 0.180 |
Why?
|
| Age of Onset | 5 | 2020 | 3271 | 0.180 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2019 | 19 | 0.180 |
Why?
|
| Leukodystrophy, Metachromatic | 1 | 2000 | 42 | 0.180 |
Why?
|
| Fractures, Spontaneous | 1 | 2001 | 230 | 0.180 |
Why?
|
| Growth Charts | 1 | 2020 | 61 | 0.180 |
Why?
|
| Maple Syrup Urine Disease | 2 | 1997 | 39 | 0.170 |
Why?
|
| Genes, X-Linked | 2 | 2011 | 128 | 0.170 |
Why?
|
| Dehydrocholesterols | 1 | 1999 | 20 | 0.170 |
Why?
|
| Homozygote | 3 | 2019 | 1785 | 0.170 |
Why?
|
| Phosphorylcholine | 1 | 2020 | 162 | 0.170 |
Why?
|
| Kidney Transplantation | 1 | 2014 | 4251 | 0.170 |
Why?
|
| Membrane Transport Proteins | 2 | 2019 | 1028 | 0.170 |
Why?
|
| Premature Birth | 2 | 2014 | 1721 | 0.170 |
Why?
|
| Exons | 4 | 2011 | 2437 | 0.170 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 1999 | 46 | 0.170 |
Why?
|
| Spasms, Infantile | 1 | 2023 | 305 | 0.170 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2021 | 294 | 0.170 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2019 | 89 | 0.170 |
Why?
|
| Oxidoreductases | 1 | 2001 | 424 | 0.160 |
Why?
|
| Lysine | 1 | 2023 | 1007 | 0.160 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 142 | 0.160 |
Why?
|
| Filipin | 1 | 2017 | 13 | 0.160 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 1622 | 0.160 |
Why?
|
| Glycogen Storage Disease Type III | 1 | 1997 | 13 | 0.160 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 555 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 6 | 2009 | 6171 | 0.160 |
Why?
|
| Genes, Recessive | 1 | 2020 | 641 | 0.160 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 426 | 0.150 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2011 | 191 | 0.150 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2002 | 373 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 2915 | 0.150 |
Why?
|
| Gastrointestinal Agents | 1 | 2002 | 494 | 0.150 |
Why?
|
| Choline | 3 | 2010 | 493 | 0.150 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2019 | 433 | 0.150 |
Why?
|
| T-Box Domain Proteins | 1 | 2020 | 471 | 0.150 |
Why?
|
| Central Nervous System Diseases | 1 | 2021 | 518 | 0.150 |
Why?
|
| Hydrops Fetalis | 1 | 2017 | 107 | 0.150 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2017 | 42 | 0.150 |
Why?
|
| Catalytic Domain | 1 | 2019 | 698 | 0.140 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2017 | 36 | 0.140 |
Why?
|
| Mutagenesis, Insertional | 1 | 2019 | 655 | 0.140 |
Why?
|
| Urinary Tract | 1 | 2020 | 309 | 0.140 |
Why?
|
| Deafness | 1 | 2021 | 458 | 0.140 |
Why?
|
| Zebrafish | 3 | 2017 | 2994 | 0.140 |
Why?
|
| High-Throughput Screening Assays | 2 | 2013 | 944 | 0.140 |
Why?
|
| Syndrome | 5 | 2020 | 3251 | 0.140 |
Why?
|
| Plasma | 1 | 2020 | 575 | 0.140 |
Why?
|
| Gluconeogenesis | 1 | 1997 | 183 | 0.140 |
Why?
|
| Mitochondrial Encephalomyopathies | 2 | 2010 | 37 | 0.140 |
Why?
|
| Genetic Diseases, X-Linked | 3 | 2012 | 372 | 0.140 |
Why?
|
| Capillary Permeability | 1 | 2020 | 798 | 0.140 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2017 | 361 | 0.140 |
Why?
|
| Medical History Taking | 1 | 2020 | 783 | 0.140 |
Why?
|
| Case-Control Studies | 8 | 2019 | 21746 | 0.140 |
Why?
|
| Benzeneacetamides | 1 | 2015 | 39 | 0.130 |
Why?
|
| Cleft Lip | 1 | 2021 | 478 | 0.130 |
Why?
|
| Craniosynostoses | 1 | 2020 | 401 | 0.130 |
Why?
|
| Protein Folding | 1 | 2019 | 843 | 0.130 |
Why?
|
| Critical Illness | 2 | 2019 | 2670 | 0.130 |
Why?
|
| Liver | 5 | 2017 | 7474 | 0.130 |
Why?
|
| Son of Sevenless Proteins | 1 | 2015 | 27 | 0.130 |
Why?
|
| Speech Disorders | 1 | 2017 | 189 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 587 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2021 | 17446 | 0.130 |
Why?
|
| Young Adult | 14 | 2020 | 56430 | 0.130 |
Why?
|
| Trihexosylceramides | 1 | 2014 | 32 | 0.130 |
Why?
|
| Phenylalanine | 2 | 2012 | 365 | 0.130 |
Why?
|
| Movement Disorders | 2 | 2017 | 445 | 0.120 |
Why?
|
| Calorimetry, Indirect | 4 | 2006 | 183 | 0.120 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 2014 | 68 | 0.120 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 12959 | 0.120 |
Why?
|
| DNA Primers | 2 | 2011 | 2892 | 0.120 |
Why?
|
| Lysosomes | 2 | 2021 | 893 | 0.120 |
Why?
|
| Specimen Handling | 2 | 2005 | 694 | 0.120 |
Why?
|
| Protein Conformation | 2 | 2015 | 4011 | 0.120 |
Why?
|
| Epilepsy | 2 | 2019 | 3310 | 0.120 |
Why?
|
| Cation Transport Proteins | 1 | 2016 | 327 | 0.110 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 748 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 3129 | 0.110 |
Why?
|
| Proteins | 2 | 2000 | 6103 | 0.110 |
Why?
|
| Manganese | 1 | 2016 | 408 | 0.110 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 2305 | 0.110 |
Why?
|
| Point Mutation | 1 | 2019 | 1623 | 0.110 |
Why?
|
| Parkinsonian Disorders | 1 | 2016 | 275 | 0.110 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 5853 | 0.110 |
Why?
|
| Austria | 3 | 2011 | 203 | 0.110 |
Why?
|
| Mannosyltransferases | 1 | 2012 | 23 | 0.110 |
Why?
|
| Chondrosarcoma | 1 | 2015 | 309 | 0.110 |
Why?
|
| Galactosemias | 1 | 2014 | 125 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1655 | 0.110 |
Why?
|
| Diet Therapy | 1 | 2014 | 154 | 0.110 |
Why?
|
| Neuroglia | 1 | 2018 | 927 | 0.110 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2018 | 835 | 0.110 |
Why?
|
| N-Acetylgalactosamine-4-Sulfatase | 1 | 2012 | 2 | 0.110 |
Why?
|
| Mucopolysaccharidosis VI | 1 | 2012 | 4 | 0.110 |
Why?
|
| Metabolic Diseases | 2 | 2008 | 658 | 0.110 |
Why?
|
| Sphingomyelins | 1 | 2012 | 105 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 1903 | 0.100 |
Why?
|
| Child Abuse | 1 | 2001 | 1030 | 0.100 |
Why?
|
| Dystonic Disorders | 1 | 2016 | 329 | 0.100 |
Why?
|
| Sensitivity and Specificity | 6 | 2020 | 14722 | 0.100 |
Why?
|
| Metabolomics | 1 | 2020 | 1484 | 0.100 |
Why?
|
| NADH Dehydrogenase | 1 | 2011 | 41 | 0.100 |
Why?
|
| Neurogenesis | 1 | 2018 | 838 | 0.100 |
Why?
|
| Animals | 14 | 2022 | 168757 | 0.100 |
Why?
|
| Models, Animal | 1 | 2017 | 2171 | 0.100 |
Why?
|
| Genetic Variation | 4 | 2019 | 6544 | 0.100 |
Why?
|
| Hexosaminidases | 1 | 2010 | 54 | 0.100 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2010 | 56 | 0.090 |
Why?
|
| Glucosylceramides | 1 | 2010 | 28 | 0.090 |
Why?
|
| Pregnancy | 7 | 2019 | 29144 | 0.090 |
Why?
|
| Astrocytes | 1 | 2018 | 1270 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 1439 | 0.090 |
Why?
|
| Reference Standards | 2 | 2012 | 1025 | 0.090 |
Why?
|
| Enzyme Stability | 1 | 2010 | 210 | 0.090 |
Why?
|
| Fibroblast Growth Factor 3 | 1 | 2010 | 17 | 0.090 |
Why?
|
| Autistic Disorder | 1 | 2020 | 1185 | 0.090 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 931 | 0.090 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 1549 | 0.090 |
Why?
|
| Electron Transport Complex I | 1 | 2011 | 140 | 0.090 |
Why?
|
| Oxidative Stress | 2 | 2012 | 3086 | 0.090 |
Why?
|
| Galactosyltransferases | 1 | 2011 | 263 | 0.090 |
Why?
|
| Tooth Abnormalities | 1 | 2010 | 54 | 0.090 |
Why?
|
| Indicators and Reagents | 1 | 2011 | 462 | 0.090 |
Why?
|
| X Chromosome Inactivation | 1 | 2012 | 224 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3647 | 0.090 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2015 | 871 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 2 | 2020 | 1613 | 0.090 |
Why?
|
| Glycogen Storage Disease Type IIb | 1 | 2009 | 18 | 0.090 |
Why?
|
| Methylmalonyl-CoA Mutase | 1 | 2009 | 22 | 0.090 |
Why?
|
| Nucleic Acid Denaturation | 2 | 2009 | 111 | 0.090 |
Why?
|
| Gene Expression | 2 | 2015 | 7799 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 3798 | 0.090 |
Why?
|
| Cell Differentiation | 3 | 2021 | 11483 | 0.090 |
Why?
|
| Chemokines, CC | 1 | 2010 | 291 | 0.090 |
Why?
|
| Glucosidases | 1 | 2008 | 13 | 0.090 |
Why?
|
| Muscle Hypotonia | 2 | 2018 | 165 | 0.090 |
Why?
|
| Retrospective Studies | 10 | 2023 | 77449 | 0.090 |
Why?
|
| DNA | 3 | 2011 | 7301 | 0.080 |
Why?
|
| Liver, Artificial | 1 | 2009 | 56 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 1213 | 0.080 |
Why?
|
| Imidazoles | 1 | 2015 | 1206 | 0.080 |
Why?
|
| Inositol | 1 | 2010 | 218 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2019 | 12208 | 0.080 |
Why?
|
| Heparin Cofactor II | 1 | 2008 | 3 | 0.080 |
Why?
|
| Glycosaminoglycans | 1 | 2012 | 624 | 0.080 |
Why?
|
| Computational Biology | 2 | 2019 | 3521 | 0.080 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 804 | 0.080 |
Why?
|
| Mucopolysaccharidoses | 1 | 2008 | 27 | 0.080 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 2007 | 8 | 0.080 |
Why?
|
| Pancytopenia | 1 | 2009 | 104 | 0.080 |
Why?
|
| Lymphedema | 1 | 2015 | 534 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2012 | 1801 | 0.080 |
Why?
|
| Research | 1 | 1997 | 1999 | 0.080 |
Why?
|
| Asymptomatic Diseases | 1 | 2011 | 551 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4751 | 0.080 |
Why?
|
| Haploinsufficiency | 2 | 2020 | 328 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 3617 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2022 | 2775 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 1142 | 0.080 |
Why?
|
| Genetic Markers | 2 | 2012 | 2634 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 4456 | 0.080 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2007 | 113 | 0.080 |
Why?
|
| Acids | 1 | 2008 | 127 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2015 | 1158 | 0.070 |
Why?
|
| Leukocytes | 2 | 2013 | 2043 | 0.070 |
Why?
|
| Carbon Dioxide | 2 | 2002 | 1150 | 0.070 |
Why?
|
| Protein Binding | 1 | 2019 | 9386 | 0.070 |
Why?
|
| Infertility | 1 | 2014 | 655 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 3920 | 0.070 |
Why?
|
| Furans | 1 | 2008 | 194 | 0.070 |
Why?
|
| Vitamin B 6 | 1 | 2008 | 237 | 0.070 |
Why?
|
| Intestinal Diseases | 1 | 2011 | 530 | 0.070 |
Why?
|
| Acetates | 1 | 2008 | 311 | 0.070 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2007 | 166 | 0.070 |
Why?
|
| Lipoproteins, HDL | 1 | 2010 | 638 | 0.070 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2006 | 98 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 276 | 0.070 |
Why?
|
| Amino Acid Substitution | 2 | 2019 | 1791 | 0.070 |
Why?
|
| Pediatrics | 1 | 2001 | 3475 | 0.070 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 2005 | 47 | 0.070 |
Why?
|
| Brain | 5 | 2018 | 26385 | 0.070 |
Why?
|
| Cross-Over Studies | 1 | 2011 | 2029 | 0.070 |
Why?
|
| Ear, Inner | 1 | 2010 | 420 | 0.070 |
Why?
|
| Thrombin | 1 | 2008 | 598 | 0.070 |
Why?
|
| Prenatal Diagnosis | 2 | 2010 | 1236 | 0.070 |
Why?
|
| Urinalysis | 1 | 2008 | 369 | 0.070 |
Why?
|
| Risk Factors | 5 | 2020 | 72290 | 0.070 |
Why?
|
| Infant, Premature | 3 | 2000 | 2044 | 0.060 |
Why?
|
| HELLP Syndrome | 1 | 2005 | 41 | 0.060 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2005 | 60 | 0.060 |
Why?
|
| Homeostasis | 1 | 2016 | 3340 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14557 | 0.060 |
Why?
|
| Basal Metabolism | 1 | 2006 | 168 | 0.060 |
Why?
|
| Codon | 1 | 2006 | 611 | 0.060 |
Why?
|
| Europe | 2 | 2010 | 3339 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2011 | 6622 | 0.060 |
Why?
|
| Methylation | 1 | 2007 | 1106 | 0.060 |
Why?
|
| Ketone Bodies | 1 | 2004 | 82 | 0.060 |
Why?
|
| Hemoglobins | 1 | 2010 | 1534 | 0.060 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 996 | 0.060 |
Why?
|
| Sex Factors | 2 | 2010 | 10397 | 0.060 |
Why?
|
| Nitrobenzoates | 1 | 2003 | 17 | 0.060 |
Why?
|
| Sudden Infant Death | 1 | 2006 | 291 | 0.060 |
Why?
|
| Treatment Outcome | 9 | 2020 | 63114 | 0.060 |
Why?
|
| Mice | 7 | 2021 | 81183 | 0.060 |
Why?
|
| Cyclohexanones | 1 | 2003 | 30 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 4 | 2014 | 7279 | 0.060 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2006 | 251 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 1889 | 0.060 |
Why?
|
| Paresthesia | 1 | 2004 | 161 | 0.060 |
Why?
|
| Toes | 1 | 2004 | 206 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 18029 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 15540 | 0.060 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2004 | 211 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2011 | 1253 | 0.060 |
Why?
|
| Myotonic Disorders | 1 | 2002 | 7 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2012 | 2132 | 0.050 |
Why?
|
| Florida | 2 | 2014 | 435 | 0.050 |
Why?
|
| Fatal Outcome | 2 | 2012 | 1850 | 0.050 |
Why?
|
| Kinetics | 3 | 2000 | 6473 | 0.050 |
Why?
|
| Vigabatrin | 1 | 2023 | 92 | 0.050 |
Why?
|
| Fasting | 2 | 2006 | 1593 | 0.050 |
Why?
|
| Germany | 2 | 2011 | 862 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2009 | 1211 | 0.050 |
Why?
|
| Milk Proteins | 1 | 2022 | 169 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2010 | 19905 | 0.050 |
Why?
|
| Liver Regeneration | 1 | 2003 | 210 | 0.050 |
Why?
|
| Meglutol | 1 | 2001 | 5 | 0.050 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 2001 | 76 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2002 | 323 | 0.050 |
Why?
|
| Insulin | 3 | 2006 | 6580 | 0.050 |
Why?
|
| Fingers | 1 | 2004 | 513 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 1997 | 2187 | 0.050 |
Why?
|
| Diet, Protein-Restricted | 1 | 2001 | 71 | 0.050 |
Why?
|
| Ilium | 1 | 2001 | 154 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2001 | 119 | 0.050 |
Why?
|
| Injections, Intramuscular | 1 | 2002 | 552 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2002 | 354 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2021 | 23403 | 0.050 |
Why?
|
| Blood Glucose | 3 | 2012 | 6256 | 0.050 |
Why?
|
| Base Sequence | 3 | 2009 | 12797 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2002 | 460 | 0.050 |
Why?
|
| Nutrition Disorders | 1 | 2001 | 211 | 0.050 |
Why?
|
| Biopsy | 3 | 2019 | 6756 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 25043 | 0.050 |
Why?
|
| Receptors, LDL | 1 | 2002 | 475 | 0.050 |
Why?
|
| Administration, Sublingual | 1 | 1999 | 56 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2004 | 981 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2012 | 2133 | 0.040 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2022 | 347 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2000 | 6600 | 0.040 |
Why?
|
| Milk | 1 | 2022 | 450 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2006 | 1318 | 0.040 |
Why?
|
| Chromosome Aberrations | 2 | 2007 | 1813 | 0.040 |
Why?
|
| Propionates | 1 | 2000 | 169 | 0.040 |
Why?
|
| Minerals | 1 | 2001 | 275 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 35421 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2006 | 3588 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 2021 | 398 | 0.040 |
Why?
|
| Diet | 1 | 2017 | 7939 | 0.040 |
Why?
|
| Middle Aged | 11 | 2020 | 213383 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2009 | 1880 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2010 | 1876 | 0.040 |
Why?
|
| Dementia, Vascular | 1 | 2000 | 128 | 0.040 |
Why?
|
| Cats | 1 | 2020 | 998 | 0.040 |
Why?
|
| Mass Screening | 1 | 2014 | 5255 | 0.040 |
Why?
|
| Seizures | 2 | 2019 | 2859 | 0.040 |
Why?
|
| Disease Progression | 3 | 2011 | 13284 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2000 | 535 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 1519 | 0.040 |
Why?
|
| Fructose Intolerance | 1 | 1997 | 8 | 0.040 |
Why?
|
| Deuterium Oxide | 1 | 1997 | 34 | 0.040 |
Why?
|
| Mass Spectrometry | 2 | 2005 | 2203 | 0.040 |
Why?
|
| Oxygen Isotopes | 1 | 1997 | 44 | 0.040 |
Why?
|
| Glycogen Storage Disease | 1 | 1997 | 41 | 0.040 |
Why?
|
| Quality Control | 2 | 2012 | 841 | 0.040 |
Why?
|
| Software | 1 | 2012 | 4443 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2000 | 406 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2017 | 738 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 315 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 9734 | 0.040 |
Why?
|
| Drugs, Investigational | 1 | 2019 | 214 | 0.040 |
Why?
|
| Disease Management | 3 | 2014 | 2459 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2011 | 4286 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2011 | 12026 | 0.040 |
Why?
|
| Family Health | 1 | 2002 | 1282 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 474 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2007 | 5456 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 961 | 0.040 |
Why?
|
| Fever | 1 | 2004 | 1616 | 0.040 |
Why?
|
| Cerebellum | 1 | 2023 | 1488 | 0.040 |
Why?
|
| Linear Models | 1 | 2007 | 5952 | 0.040 |
Why?
|
| Models, Biological | 2 | 2007 | 9583 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 1998 | 374 | 0.030 |
Why?
|
| Neocortex | 1 | 2020 | 400 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 976 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2021 | 859 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2004 | 1809 | 0.030 |
Why?
|
| alpha-Synuclein | 1 | 2022 | 723 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2001 | 817 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2012 | 3445 | 0.030 |
Why?
|
| Hydrocephalus | 1 | 2002 | 748 | 0.030 |
Why?
|
| Introns | 2 | 2011 | 991 | 0.030 |
Why?
|
| Cohort Studies | 5 | 2020 | 40561 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 1017 | 0.030 |
Why?
|
| Basal Ganglia | 1 | 2018 | 546 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 326 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2018 | 835 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 1997 | 393 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 5867 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2002 | 3913 | 0.030 |
Why?
|
| Fish Oils | 1 | 1998 | 470 | 0.030 |
Why?
|
| Genetics, Medical | 1 | 2017 | 338 | 0.030 |
Why?
|
| Reference Values | 1 | 2001 | 4982 | 0.030 |
Why?
|
| Age Distribution | 2 | 2010 | 2902 | 0.030 |
Why?
|
| Autophagy | 1 | 2021 | 1300 | 0.030 |
Why?
|
| Dystonia | 1 | 2017 | 363 | 0.030 |
Why?
|
| Cell Line | 2 | 2010 | 15997 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2014 | 168 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 15519 | 0.030 |
Why?
|
| Prenatal Care | 2 | 2014 | 1092 | 0.030 |
Why?
|
| Finland | 1 | 2014 | 602 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2023 | 1916 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2003 | 1863 | 0.030 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2013 | 111 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2014 | 440 | 0.030 |
Why?
|
| Lipoproteins | 1 | 1998 | 878 | 0.030 |
Why?
|
| Galactose | 1 | 2014 | 306 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1117 | 0.030 |
Why?
|
| Niemann-Pick Diseases | 1 | 2012 | 28 | 0.030 |
Why?
|
| Galactosylceramidase | 1 | 2012 | 19 | 0.030 |
Why?
|
| Drosophila | 1 | 2020 | 1491 | 0.030 |
Why?
|
| Antigens | 1 | 2018 | 1466 | 0.030 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2012 | 14 | 0.030 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2012 | 32 | 0.030 |
Why?
|
| Recurrence | 1 | 2004 | 8340 | 0.030 |
Why?
|
| Aging | 2 | 2009 | 8664 | 0.030 |
Why?
|
| Cephalometry | 1 | 2013 | 382 | 0.030 |
Why?
|
| Retina | 1 | 2023 | 2616 | 0.030 |
Why?
|
| Aged | 8 | 2020 | 163280 | 0.030 |
Why?
|
| Placenta Diseases | 1 | 2014 | 199 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2019 | 2751 | 0.030 |
Why?
|
| Body Composition | 1 | 2001 | 2401 | 0.030 |
Why?
|
| Switzerland | 1 | 2011 | 255 | 0.020 |
Why?
|
| Minnesota | 1 | 2012 | 344 | 0.020 |
Why?
|
| Lactation | 1 | 2014 | 412 | 0.020 |
Why?
|
| Glutathione | 1 | 2014 | 589 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2019 | 1058 | 0.020 |
Why?
|
| Data Collection | 2 | 2010 | 3341 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2020 | 1708 | 0.020 |
Why?
|
| Prognosis | 2 | 2009 | 29063 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 5391 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2019 | 13033 | 0.020 |
Why?
|
| Health Expenditures | 1 | 2023 | 2348 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2011 | 505 | 0.020 |
Why?
|
| Career Choice | 1 | 1997 | 744 | 0.020 |
Why?
|
| Health Planning Organizations | 1 | 2010 | 12 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2019 | 53288 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 780 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2015 | 804 | 0.020 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2010 | 52 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 1405 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2015 | 1285 | 0.020 |
Why?
|
| Cobamides | 1 | 2009 | 12 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 13881 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2009 | 52 | 0.020 |
Why?
|
| Hemoglobinopathies | 1 | 2010 | 96 | 0.020 |
Why?
|
| Hypospadias | 1 | 2010 | 92 | 0.020 |
Why?
|
| Consensus | 1 | 2018 | 2959 | 0.020 |
Why?
|
| Hyperammonemia | 1 | 2010 | 76 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2012 | 981 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2010 | 163 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2018 | 2504 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2014 | 1184 | 0.020 |
Why?
|
| Cryptorchidism | 1 | 2010 | 125 | 0.020 |
Why?
|
| Cognition | 2 | 2020 | 6770 | 0.020 |
Why?
|
| Demography | 1 | 2014 | 1656 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2009 | 244 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 5708 | 0.020 |
Why?
|
| Vitamin B Deficiency | 1 | 2008 | 13 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 281 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2009 | 424 | 0.020 |
Why?
|
| Child Development | 1 | 2019 | 2223 | 0.020 |
Why?
|
| Carboxylic Acids | 1 | 2008 | 97 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2011 | 1266 | 0.020 |
Why?
|
| Hyperhomocysteinemia | 1 | 2008 | 124 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2009 | 399 | 0.020 |
Why?
|
| Hippocampus | 1 | 2020 | 3675 | 0.020 |
Why?
|
| Dextrans | 1 | 2009 | 595 | 0.020 |
Why?
|
| Cell Size | 1 | 2009 | 643 | 0.020 |
Why?
|
| Metalloproteins | 1 | 2007 | 100 | 0.020 |
Why?
|
| Ions | 1 | 2008 | 265 | 0.020 |
Why?
|
| Czech Republic | 1 | 2006 | 69 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2008 | 211 | 0.020 |
Why?
|
| Urea | 1 | 2009 | 450 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4204 | 0.020 |
Why?
|
| Solvents | 1 | 2008 | 302 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 6993 | 0.020 |
Why?
|
| Albumins | 1 | 2009 | 569 | 0.020 |
Why?
|
| Microspheres | 1 | 2009 | 777 | 0.020 |
Why?
|
| Lipotropic Agents | 1 | 2005 | 14 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 15165 | 0.020 |
Why?
|
| Urban Population | 1 | 2014 | 2021 | 0.020 |
Why?
|
| Skin | 1 | 2019 | 4364 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 1005 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5319 | 0.020 |
Why?
|
| International Cooperation | 1 | 2012 | 1420 | 0.020 |
Why?
|
| Metabolome | 1 | 2012 | 895 | 0.020 |
Why?
|
| Research Design | 1 | 2001 | 5987 | 0.020 |
Why?
|
| Time Factors | 1 | 2007 | 40075 | 0.020 |
Why?
|
| Placenta | 1 | 2014 | 1698 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 1856 | 0.020 |
Why?
|
| Food, Formulated | 1 | 2005 | 109 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 2014 | 1200 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2009 | 1526 | 0.020 |
Why?
|
| Insulin Antibodies | 1 | 2004 | 31 | 0.020 |
Why?
|
| Kidney | 1 | 2020 | 7186 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 1901 | 0.020 |
Why?
|
| Diabetes, Gestational | 1 | 2014 | 1184 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 57776 | 0.020 |
Why?
|
| Lateral Ventricles | 1 | 2005 | 146 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2019 | 6150 | 0.020 |
Why?
|
| Receptor, Notch1 | 1 | 2007 | 502 | 0.010 |
Why?
|
| Outpatients | 1 | 2011 | 1486 | 0.010 |
Why?
|
| Deficiency Diseases | 1 | 2004 | 72 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 2011 | 7913 | 0.010 |
Why?
|
| Students, Medical | 1 | 1997 | 1862 | 0.010 |
Why?
|
| Clone Cells | 1 | 2007 | 1692 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2011 | 2617 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 1970 | 0.010 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2003 | 41 | 0.010 |
Why?
|
| Incidence | 1 | 2001 | 20947 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2274 | 0.010 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2004 | 271 | 0.010 |
Why?
|
| Calibration | 1 | 2005 | 816 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2004 | 569 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3610 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 2716 | 0.010 |
Why?
|
| Glucagon | 1 | 2004 | 533 | 0.010 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2004 | 390 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 1420 | 0.010 |
Why?
|
| S-Adenosylmethionine | 1 | 2003 | 212 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 1678 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2007 | 1114 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3870 | 0.010 |
Why?
|
| Genomics | 1 | 2017 | 5720 | 0.010 |
Why?
|
| Atrophy | 1 | 2005 | 1583 | 0.010 |
Why?
|
| Muscle, Skeletal | 2 | 2009 | 4931 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2001 | 803 | 0.010 |
Why?
|
| Monosomy | 1 | 2000 | 54 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 2000 | 278 | 0.010 |
Why?
|
| Karyotyping | 1 | 2002 | 1243 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 846 | 0.010 |
Why?
|
| Body Constitution | 1 | 2000 | 278 | 0.010 |
Why?
|
| Capnography | 1 | 2000 | 89 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 1801 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2004 | 1154 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 2000 | 467 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8324 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2011 | 4217 | 0.010 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2005 | 957 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9727 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 16689 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12245 | 0.010 |
Why?
|
| Apolipoprotein B-100 | 1 | 1998 | 148 | 0.010 |
Why?
|
| Remission Induction | 1 | 2003 | 2386 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 13815 | 0.010 |
Why?
|
| Lipoproteins, VLDL | 1 | 1998 | 201 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2012 | 7729 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 2916 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 1420 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2009 | 10252 | 0.010 |
Why?
|
| Myocardium | 1 | 2009 | 4776 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 18111 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1998 | 402 | 0.010 |
Why?
|
| Body Mass Index | 2 | 2008 | 12720 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2009 | 3110 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15076 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2002 | 2649 | 0.010 |
Why?
|
| Lipase | 1 | 1998 | 314 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2004 | 2035 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2007 | 4554 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 4042 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 5442 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 23338 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 8436 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 13989 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2005 | 4043 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2000 | 5078 | 0.010 |
Why?
|
| Triglycerides | 1 | 1998 | 2454 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2000 | 3494 | 0.010 |
Why?
|
| Prevalence | 1 | 2006 | 15226 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2000 | 2569 | 0.010 |
Why?
|
| United States | 1 | 2014 | 69872 | 0.000 |
Why?
|